Cardiovascular disease, sometimes abbreviated as CVD, is the leading cause of death worldwide. It’s a catchall term for heart ...

Heart disease is expected to affect 61% of US adults by 2050, so it’s important to know when problems may be afoot.

Learn about Peripheral Artery Disease (PAD) and its impact on the Black community. Discover the risks, symptoms, and treatment options for this irreversible medical condition.

Netherlands-based diagnostics imaging company Royal Philips announced the enrolment of its first patient in the US THRO IDE ...

Abbott has delivered new, longer-term data from a clinical study of its dissolving stent for severe peripheral artery disease ...

Johnson & Johnson MedTech's Shockwave Medical unit today announced the first clinical outcomes associated with its Javelin ...

With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a ...

Diabetic Ulcers are a serious complication that can lead to serious complications for those that suffer from them, but there ...

Interventional cardiologist Dr. Ross Melvin joins us to give a demonstration of the new technology available to treat peripheral arterial disease.

This is the first hospital in North Texas to offer the treatment for patients suffering from complex peripheral artery ...

Discover why LeMaitre's expansion in the peripheral vascular disease market and strong dividend growth make it an appealing ...

Humacyte ( (HUMA) ) has released its Q3 earnings. Here is a breakdown of the information Humacyte presented to its investors. Humacyte, Inc., a ...